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Clinics and pathology 
Disease 
Acute undifferentiated leukemia (AUL). 
Epidemiology 
Only one case described so far. 
Cytogenetics 
Note: the only SET-NUP214 positive case described so 
far had a normal karyotype; on the cytogenetic level it 
is unclear if the SET-NUP214 fusion is generated by a 
t(9;9)(q34;q34) or an interstitial deletion at 9q34; the 
latter is supported by the centromere-telomere 
orientation of both genes and their local order: 
centromere-SET-NUP214-telomere. 
Cytogenetics morphological 
The single case described so far had a normal 
karyotype; may be overlooked. 
Genes involved and Proteins 
SET 
Location: 9q34 
DNA / RNA 
8 exons spanning 6,81 kb of genomic DNA; 2559 bp 
mRNA. 
Protein 
Two isoforms; isoform 1 (TAF1 alpha) 290 amino 
acids, 33.5 kDa; isoform 2 (TAF1 beta) - 277 amino 
acids, 23.1 kDa; DNA associated, transcription factor; 
multitasking protein, involved in apoptosis, 
transcription, nucleosome assembly and histone 
binding; cytoplasmic and nuclear; in the cytoplasm,  
 
 




DNA / RNA 
36 exons encompassing about 108 kb of genomic 
DNA; 6.6 kb mRNA. 
Protein 
2090 amino acids, 213.8 kDa; forms homodimers, 
contains two leucine zipper dimerization domains, and
FG repeats at the C-terminus, which are homologous t  
those observed in other members of the nucleoporin 
family; expressed in thymus, spleen, bone marrow, 
kidney, brain and testis, but hardly in all other tissues 
or in whole embryos during development; may serve as 
a docking site in the receptor-mediated import of 
substrates across the nuclear pore complex (NPC); 
intracellular localization, cytoplasmic face of the NPC. 




5' SET - 3' NUP214 
Fusion protein 
Description 
The SET-NUP214 fusion protein consists of almost the 
whole SET protein fused to the C-terminus of NUP214; 
155 kDa. 
Oncogenesis 
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